Web Analytics

fundsforNGOs

Grants and Resources for Sustainability

You are here: Home / Grant / Pfizer-Supported Education on Baseline Assessments for Ulcerative Colitis (US)

Pfizer-Supported Education on Baseline Assessments for Ulcerative Colitis (US)

Deadline: 14-Apr-2026

Pfizer is inviting U.S.-based organizations to apply for funding of up to $100,000 for independent medical education projects. The initiative focuses on training healthcare professionals in baseline evaluations—ECG, eye, and skin assessments—for adults with moderately to severely active ulcerative colitis starting sphingosine 1-phosphate receptor modulator (S1Prm) therapy.

Program Overview

The Pfizer Medical Education Initiative aims to address critical knowledge gaps among healthcare professionals managing adults with ulcerative colitis who are initiating S1Prm therapy. The program emphasizes interdisciplinary collaboration, integrating expertise from:

  • Gastroenterology

  • Cardiology and electrophysiology

  • S1Prm pharmacology

  • Dermatology and ophthalmology

By focusing on baseline evaluations and patient selection, the initiative supports safer treatment decisions and improved outcomes for patients.

Key Focus Areas

Educational projects should emphasize the following:

  1. Baseline Assessments for S1Prm Therapy

    • Understanding the role of electrocardiogram (ECG) and conduction assessment in patient selection

    • Performing ECG, eye exams, and skin exams before initiating therapy

    • Ensuring adherence to current U.S. prescribing information

  2. Interdisciplinary Collaboration

    • Integrating insights from multiple specialties to provide comprehensive training

    • Encouraging knowledge sharing across gastroenterology, cardiology, dermatology, ophthalmology, and pharmacology

  3. Enhancing Clinical Competency

    • Addressing knowledge gaps to improve patient safety

    • Optimizing treatment decisions and outcomes for adults starting S1Prm therapy

Funding and Eligibility

  • Funding Amount: Up to $100,000 USD per project

  • Project Duration: Maximum of six months

  • Eligible Applicants:

    • Medical institutions

    • Professional societies

    • Healthcare education companies

    • Other organizations with a mission to advance healthcare professional education or improve healthcare delivery

  • Ineligible Applicants: Individual physicians or independent practice groups

Requirements:

  • The Project Lead must be an authorized employee or contractor of the requesting organization.

  • All collaborating institutions must have clearly defined roles.

  • Projects offering continuing education credit must be conducted through accredited organizations.

  • Applicants should confirm their ability to accept direct funding from Pfizer.

  • Projects must be based in the United States.

How to Apply

Step 1: Confirm Eligibility

  • Ensure your organization is U.S.-based and eligible to receive Pfizer funding.

  • Verify accreditation status if offering continuing education credit.

Step 2: Define Project Scope

  • Focus on baseline evaluations (ECG, eye, and skin assessments) for S1Prm therapy.

  • Plan interdisciplinary collaboration for comprehensive training.

  • Specify expected outcomes for healthcare professional competency and patient safety.

Step 3: Prepare Budget and Timeline

  • Request funding up to $100,000 USD.

  • Outline project duration, milestones, and deliverables (max six months).

Step 4: Submit Application

  • Include project objectives, curriculum or educational plan, collaborating institutions, budget, and anticipated outcomes.

Tips for Success

  • Highlight interdisciplinary approach and practical training applications.

  • Demonstrate clear impact on clinical competency and patient safety.

  • Ensure the project aligns with current prescribing information for S1Prm therapy.

  • Include a detailed plan for execution within six months.

  • For CE projects, confirm accreditation requirements in advance.

Frequently Asked Questions (FAQs)

  1. Who can apply for funding?
    U.S.-based medical institutions, professional societies, healthcare education companies, and other relevant organizations.

  2. What is the maximum funding available?
    Up to $100,000 USD per project.

  3. What is the maximum project duration?
    Six months.

  4. Can individual physicians apply directly?
    No, individual physicians and independent practice groups are ineligible.

  5. Are continuing education projects eligible?
    Yes, but they must be conducted through accredited organizations.

  6. What are the key educational focus areas?
    ECG and conduction assessment, eye and skin exams, and adherence to U.S. prescribing information for S1Prm therapy.

  7. What is the main goal of the initiative?
    To enhance healthcare professional competency, improve patient safety, and optimize outcomes for adults starting S1Prm therapy.

Conclusion

The Pfizer Medical Education Initiative offers a unique opportunity for organizations to deliver focused, practical training for healthcare professionals managing adults with ulcerative colitis. By emphasizing baseline assessments, interdisciplinary collaboration, and adherence to prescribing guidance, the program aims to bridge knowledge gaps, improve clinical decision-making, and enhance patient outcomes.

For more information, visit Pfizer.